Search Results - "Jones, R.J"

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial by Clarke, N.W., Ali, A., Ingleby, F.C., Hoyle, A., Amos, C.L., Attard, G., Brawley, C.D., Calvert, J., Chowdhury, S., Cook, A., Cross, W., Dearnaley, D.P., Douis, H., Gilbert, D., Gillessen, S., Jones, R.J., Langley, R.E., MacNair, A., Malik, Z., Mason, M.D., Matheson, D., Millman, R., Parker, C.C., Ritchie, A.W.S., Rush, H., Russell, J.M., Brown, J., Beesley, S., Birtle, A., Capaldi, L., Gale, J., Gibbs, S., Lydon, A., Nikapota, A., Omlin, A., O'Sullivan, J.M., Parikh, O., Protheroe, A., Rudman, S., Srihari, N.N., Simms, M., Tanguay, J.S., Tolan, S., Wagstaff, J., Wallace, J., Wylie, J., Zarkar, A., Sydes, M.R., Parmar, M.K.B., James, N.D.

“…STAMPEDE has previously reported that the use of upfront docetaxel improved overall survival (OS) for metastatic hormone naïve prostate cancer patients…”
Get full text

Using diffusion MRI data acquired with ultra-high gradient strength to improve tractography in routine-quality data by Maffei, C., Lee, C., Planich, M., Ramprasad, M., Ravi, N., Trainor, D., Urban, Z., Kim, M., Jones, R.J., Henin, A., Hofmann, S.G., Pizzagalli, D.A., Auerbach, R.P., Gabrieli, J.D.E., Whitfield-Gabrieli, S., Greve, D.N., Haber, S.N., Yendiki, A.

“…The development of scanners with ultra-high gradient strength, spearheaded by the Human Connectome Project, has led to dramatic improvements in the spatial,…”
Get full text

Management of metastatic castration-resistant prostate cancer after first-line docetaxel by Harrington, J.A, Jones, R.J

“…Abstract Although chemotherapy, based on docetaxel, is now established in the management of metastatic castration-resistant prostate cancer (mCRPC), until…”
Get full text

Evaluation of stored lamb bio-preserved using a three-strain cocktail of Lactobacillus sakei by Jones, R.J., Wiklund, E., Zagorec, M., Tagg, J.R.

“…Commercially prepared lamb was stored at −1.5 °C after inoculation with a combination of three Lactobacillus sakei strains previously shown to inhibit spoilage…”
Get full text

19LBA Docetaxel (Doc) +/− zoledronic acid (ZA) for hormone-naive prostate cancer: First overall survival results from STAMPEDE & treatment effects within subgroups (NCT00268476) by James, N.D, Sydes, M.R, Mason, M.D, Clarke, N.W, Dearnaley, D.P, Spears, M.R, Millman, R, Parker, C.C, Ritchie, A.W.S, Russell, J.M, Staffurth, J, Jones, R.J, Cathomas, R, Robinson, A, Chowdhury, S, Tsang, D, Brock, S, Parikh, O, Graham, J.D, Parmar, M.K.B

Get full text

7105 POSTER DISCUSSION Belinostat in Combination With Carboplatin and Paclitaxel (BelCaP) for Treatment of Bladder Cancer – A Pharmacokinetic Study of Exposure to Belinostat and Its Metabolites by Jones, R.J, Tjornelund, J, Erichsen, K.D, Sengelov, L, De Bono, J

Get full text

DMSP in Corals and Benthic Algae from the Great Barrier Reef by Broadbent, A.D., Jones, G.B., Jones, R.J.

“…In this study the first measurements of DMSP in six species of corals and ten species of benthic algae collected from four coral reefs in the Great Barrier…”
Get full text

Tumour Flare during Interruption of Temsirolimus Treatment for Metastatic Renal Cell Cancer by Paterson, C, Jones, R.J

Get full text

PAM Chlorophyll Fluorometry: a New in situ Technique for Stress Assessment in Scleractinian Corals, used to Examine the Effects of Cyanide from Cyanide Fishing by Jones, R.J., Kildea, T., Hoegh-guldberg, O.

“…Sodium cyanide is being used on reefs in the Asia–Pacific region to capture live fish for the aquarium industry, and to supply a rapidly growing,…”
Get full text

Detailed studies and control of intensity-related dynamics of femtosecond frequency combs from mode-locked Ti:sapphire lasers by Holman, K.W., Jones, R.J., Marian, A., Cundiff, S.T., Jun Ye

“…The authors have conducted detailed experimental investigations of the intensity-related dynamics of the pulse repetition and carrier-envelope offset…”
Get full text

7000 ORAL Final Overall Survival (OS) Analysis of COU-AA-301, a Phase 3 Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Pretreated With Docetaxel by Fizazi, K, Scher, H.I, Molina, A, Logothetis, C.J, Jones, R.J, Staffurth, J.N, Li, J, Kheoh, T, Haqq, C.M, de Bono, J.S

Get full text

P1.105 Top-down in.uence on a visually evoked locomotor steering response by Reed-Jones, R.J, Vallis, L.A, Trick, L.M

Get full text

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy by James, Nicholas D, de Bono, Johann S, Spears, Melissa R, Clarke, Noel W, Mason, Malcolm D, Dearnaley, David P, Ritchie, Alastair W.S, Amos, Claire L, Gilson, Clare, Jones, Rob J, Matheson, David, Millman, Robin, Attard, Gerhardt, Chowdhury, Simon, Cross, William R, Gillessen, Silke, Parker, Christopher C, Russell, J. Martin, Berthold, Dominik R, Brawley, Chris, Adab, Fawzi, Aung, San, Birtle, Alison J, Bowen, Jo, Brock, Susannah, Chakraborti, Prabir, Ferguson, Catherine, Gale, Joanna, Gray, Emma, Hingorani, Mohan, Hoskin, Peter J, Lester, Jason F, Malik, Zafar I, McKinna, Fiona, McPhail, Neil, Money-Kyrle, Julian, O’Sullivan, Joe, Parikh, Omi, Protheroe, Andrew, Robinson, Angus, Srihari, Narayanan N, Thomas, Carys, Wagstaff, John, Wylie, James, Zarkar, Anjali, Parmar, Mahesh K.B, Sydes, Matthew R

“…The addition of abiraterone and prednisolone to standard androgen-deprivation therapy as the first treatment for patients with locally advanced or metastatic…”
Get full text

Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide by O'Donnell, P.V, Luznik, L, Jones, R.J, Vogelsang, G.B, Leffell, M.S, Phelps, M, Rhubart, P, Cowan, K, Piantadosi, S, Fuchs, E.J

“…Cyclophosphamide (Cy) is a potent immunosuppressive agent that is selectively toxic to lymphocytes proliferating in response to recent antigen stimulation. In…”
Get full text

Hydrogel-assisted self-healing of biomineralized living building materials by Delesky, E.A., Jones, R.J., Cook, S.M., Cameron, J.C., Hubler, M.H., Srubar, W.V.

“…Living building materials (LBMs) are an emergent class of structural materials that leverage the biomineralization capability of microorganisms within…”
Get full text

Recovery and enhanced yields of volatile fatty acids from a grass fermentation via in-situ solids separation and electrodialysis by Jones, R.J., Massanet-Nicolau, J., Fernandez-Feito, R., Dinsdale, R.M., Guwy, A.J.

“…An industrially applicable methodology utilising a novel combination of filtration and electrochemical separation technologies was successfully used to…”
Get full text

1812P Exploration of germline (g) vs somatic (s) origin of homologous recombination repair (HRR) gene alterations and potential associations with antitumor activity in the HRR-deficient population from TALAPRO-2 by Yip, S.M., Fizazi, K., Matsubara, N., Azad, A.A., Joung, J.Y., Fong, P.C., Carles Galceran, J., De Giorgi, U.F.F., Jones, R.J., Liu, G., Fay, A.P., Voog, E., Zschäbitz, S., Oldenburg, J., Di Santo, N., Healy, C.G., Lin, X., Laird, D., Agarwal, N.

Get full text

1811P Patient-reported outcomes (PROs) in men with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) mutations receiving talazoparib (TALA) + enzalutamide (ENZA) vs placebo (PBO) + ENZA: Results from a phase III (TALAPRO-2) study by Fay, A.P., Fizazi, K., Matsubara, N., Azad, A.A., Saad, F., De Giorgi, U.F.F., Joung, J.Y., Fong, P.C., Jones, R.J., Zschäbitz, S., Oldenburg, J., Shore, N.D., Dunshee, C., Carles Galceran, J., Cislo, P., Chang, J., Healy, C.G., Niyazov, A., Agarwal, N.

Get full text

Fermentative volatile fatty acid production and recovery from grass using a novel combination of solids separation, pervaporation, and electrodialysis technologies by Jones, R.J., Massanet-Nicolau, J., Fernandez–Feito, R, Dinsdale, R.M., Guwy, A.J.

“…•System recovered VFAs from continually fed 83 L grass bioreactor over 3, 7–day HRTs.•4,500 mg L-1 solution of VFAs produced, suitable for platform chemical…”
Get full text

1807P Talazoparib (TALA) plus enzalutamide (ENZA) in metastatic castration-resistant prostate cancer (mCRPC): Subgroup analyses of the all-comers cohort from TALAPRO-2 by homologous recombination repair (HRR) status by Matsubara, N., Fizazi, K., Azad, A.A., Carles Galceran, J., Fay, A.P., De Giorgi, U.F.F., Joung, J.Y., Fong, P.C., Voog, E., Jones, R.J., Shore, N.D., Dunshee, C., Zschäbitz, S., Karsh, L.I., Barthelemy, P., Lin, X., Healy, C.G., Di Santo, N., Zohren, F., Agarwal, N.

Get full text